ACM
ATYR

ADAR1 Capital Management’s aTyr Pharma ATYR Stock Holding History

ADAR1 Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-222,500
Closed -$161K – 302
2025
Q3 		$161K Buy
222,500
+172,500
+345% +$782K 0.02% 188
2025
Q2 		$254K Buy
+50,000
New +$197K 0.04% 147

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management's ATYR Position: Q1 2026 in Review

ADAR1 Capital Management held its aTyr Pharma (ATYR) position steady in Q1 2026 at 50,685 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

ADAR1 Capital Management first reported a position in ATYR in Q3 2025 and has held it in 3 quarters since. The position peaked at $126K in Q3 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

  • ADAR1 Capital Management held 50,685 shares of aTyr Pharma worth $39.5K as of Q1 2026.
  • ADAR1 Capital Management left its aTyr Pharma share count unchanged in Q1 2026.
  • aTyr Pharma made up ﹤0.01% of ADAR1 Capital Management's portfolio in Q1 2026, its #303 holding.
  • ADAR1 Capital Management first reported a position in aTyr Pharma in Q3 2025 and has held it in 3 quarters since.
  • ADAR1 Capital Management's aTyr Pharma position peaked at $126K in Q3 2025.
  • 111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on ADAR1 Capital Management's 13F filing for Q1 2026, filed 18 May 2026.